Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 278

1.

Quetiapine versus olanzapine for the treatment of negative symptoms in patients with schizophrenia.

Sirota P, Pannet I, Koren A, Tchernichovsky E.

Hum Psychopharmacol. 2006 Jun;21(4):227-34.

PMID:
16783811
[PubMed - indexed for MEDLINE]
2.

Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia.

Riedel M, Müller N, Spellmann I, Engel RR, Musil R, Valdevit R, Dehning S, Douhet A, Cerovecki A, Strassnig M, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2007 Oct;257(7):402-12.

PMID:
17629725
[PubMed - indexed for MEDLINE]
3.

Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.

Dossenbach M, Erol A, el Mahfoud Kessaci M, Shaheen MO, Sunbol MM, Boland J, Hodge A, O'Halloran RA, Bitter I; IC-SOHO Study Group.

J Clin Psychiatry. 2004 Mar;65(3):312-21.

PMID:
15096069
[PubMed - indexed for MEDLINE]
4.

Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.

Riedel M, Spellmann I, Strassnig M, Douhet A, Dehning S, Opgen-Rhein M, Valdevit R, Engel RR, Kleindienst N, Müller N, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2007 Sep;257(6):360-70. Epub 2007 Jul 14.

PMID:
17629731
[PubMed - indexed for MEDLINE]
5.

Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms.

Riedel M, Müller N, Strassnig M, Spellmann I, Engel RR, Musil R, Dehning S, Douhet A, Schwarz MJ, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2005 Dec;255(6):432-7. Epub 2005 Nov 4.

PMID:
16267634
[PubMed - indexed for MEDLINE]
6.

A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.

Sacchetti E, Valsecchi P, Parrinello G; QUERISOLA Group.

Schizophr Res. 2008 Jan;98(1-3):55-65. Epub 2007 Oct 15.

PMID:
17933497
[PubMed - indexed for MEDLINE]
7.

Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.

Buckley PF.

Curr Med Res Opin. 2004 Sep;20(9):1357-63.

PMID:
15383183
[PubMed - indexed for MEDLINE]
8.

Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning.

Kinon BJ, Noordsy DL, Liu-Seifert H, Gulliver AH, Ascher-Svanum H, Kollack-Walker S.

J Clin Psychopharmacol. 2006 Oct;26(5):453-61. Erratum in: J Clin Psychopharmacol. 2009 Apr;29(2):169.

PMID:
16974184
[PubMed - indexed for MEDLINE]
9.
10.

Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study.

Zhong KX, Sweitzer DE, Hamer RM, Lieberman JA.

J Clin Psychiatry. 2006 Jul;67(7):1093-103.

PMID:
16889453
[PubMed - indexed for MEDLINE]
11.

Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.

Dossenbach M, Pecenak J, Szulc A, Irimia V, Anders M, Logozar-Perkovic D, Peciukaitiene D, Kotler M, Smulevich AB, West TM, Lowry AJ, Treuer T.

J Clin Psychiatry. 2008 Dec;69(12):1901-15. Epub 2008 Sep 9.

PMID:
19012820
[PubMed - indexed for MEDLINE]
12.

A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia.

Alvarez E, Ciudad A, Olivares JM, Bousoño M, Gómez JC.

J Clin Psychopharmacol. 2006 Jun;26(3):238-49.

PMID:
16702888
[PubMed - indexed for MEDLINE]
13.

Quetiapine in hospitalized patients with schizophrenia refractory to treatment with first-generation antipsychotics: a 4-week, flexible-dose, single-blind, exploratory, pilot trial.

Sacchetti E, Panariello A, Regini C, Valsecchi P.

Schizophr Res. 2004 Aug 1;69(2-3):325-31.

PMID:
15469204
[PubMed - indexed for MEDLINE]
14.

How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.

Suzuki T, Uchida H, Watanabe K, Nomura K, Takeuchi H, Tomita M, Tsunoda K, Nio S, Den R, Manki H, Tanabe A, Yagi G, Kashima H.

Psychopharmacology (Berl). 2007 Dec;195(2):285-95. Epub 2007 Aug 14.

PMID:
17701027
[PubMed - indexed for MEDLINE]
15.

Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.

Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Capuano GA, Rosenheck RA, Keefe RS, Miller AL, Belz I, Hsiao JK; CATIE Investigators.

Am J Psychiatry. 2007 Mar;164(3):415-27.

PMID:
17329466
[PubMed - indexed for MEDLINE]
16.

Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function.

Rainer M, Haushofer M, Pfolz H, Struhal C, Wick W.

Eur Psychiatry. 2007 Sep;22(6):395-403. Epub 2007 May 4.

PMID:
17482432
[PubMed - indexed for MEDLINE]
17.

Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia.

Kasper S, Brecher M, Fitton L, Jones AM.

Int Clin Psychopharmacol. 2004 Sep;19(5):281-9. Erratum in: Int Clin Psychopharmacol. 2004 Nov;19(6):363.

PMID:
15289701
[PubMed - indexed for MEDLINE]
18.

[A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].

István S, Agoston T, Tamás T, Zoltán J.

Neuropsychopharmacol Hung. 2007 Oct;9(3):115-24. Hungarian.

PMID:
18399029
[PubMed - indexed for MEDLINE]
Free Article
19.

Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone.

Larmo I, de Nayer A, Windhager E, Lindenbauer B, Rittmannsberger H, Platz T, Jones AM, Altman C; Spectrum Study Group.

Hum Psychopharmacol. 2005 Dec;20(8):573-81.

PMID:
16175656
[PubMed - indexed for MEDLINE]
20.

Quetiapine. A review of its use in the management of schizophrenia.

Cheer SM, Wagstaff AJ.

CNS Drugs. 2004;18(3):173-99. Review.

PMID:
14871161
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk